3
|
Chou KL, Martello J, Atem J, Elrod M, Foster ER, Freshwater K, Gunzler SA, Kim H, Mahajan A, Sarva H, Stebbins GT, Lee E, Yang L. Quality Improvement in Neurology: 2020 Parkinson Disease Quality Measurement Set Update. Neurology 2021; 97:239-245. [PMID: 34341076 DOI: 10.1212/wnl.0000000000012198] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Accepted: 04/07/2021] [Indexed: 12/13/2022] Open
Affiliation(s)
- Kelvin L Chou
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Justin Martello
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Juliana Atem
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Matt Elrod
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Erin R Foster
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Karen Freshwater
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Steven A Gunzler
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Hojoong Kim
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Abhimanyu Mahajan
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Harini Sarva
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Glenn T Stebbins
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| | - Erin Lee
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA.
| | - Laurice Yang
- From the University of Michigan Medical School (K.L.C.), Ann Arbor; Christiana Care (J.M.), Wilmington, DE; UT Southwestern Medical Center (J.A.), Dallas, TX; MaxMD (M.E.), Fort Lee, NJ; Washington University School of Medicine (E.R.F.), St. Louis, MO; Bronson Neuroscience Center (K.F.), Kalamazoo, MI; University Hospitals Cleveland Medical Center and Case Western Reserve University (S.A.G.), OH; Veterans Affairs Puget Sound Health Care System (H.K.), Seattle, WA; Rush University Medical Center (A.M.), Chicago, IL; Weill Cornell Medicine (H.S.), New York, NY; Rush University (G.T.S.), Chicago, IL; American Academy of Neurology (E.L.), Minneapolis, MN; and Stanford Health Care (L.Y.), Palo Alto, CA
| |
Collapse
|
4
|
van Munster M, Stümpel J, Thieken F, J. Pedrosa D, Antonini A, Côté D, Fabbri M, Ferreira JJ, Růžička E, Grimes D, Mestre TA. Moving towards Integrated and Personalized Care in Parkinson's Disease: A Framework Proposal for Training Parkinson Nurses. J Pers Med 2021; 11:623. [PMID: 34209024 PMCID: PMC8304750 DOI: 10.3390/jpm11070623] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Revised: 06/17/2021] [Accepted: 06/25/2021] [Indexed: 12/28/2022] Open
Abstract
Delivering healthcare to people living with Parkinson's disease (PD) may be challenging in face of differentiated care needs during a PD journey and a growing complexity. In this regard, integrative care models may foster flexible solutions on patients' care needs whereas Parkinson Nurses (PN) may be pivotal facilitators. However, at present hardly any training opportunities tailored to the care priorities of PD-patients are to be found for nurses. Following a conceptual approach, this article aims at setting a framework for training PN by reviewing existing literature on care priorities for PD. As a result, six prerequisites were formulated concerning a framework for training PN. The proposed training framework consist of three modules covering topics of PD: (i) comprehensive care, (ii) self-management support and (iii) health coaching. A fourth module on telemedicine may be added if applicable. The framework streamlines important theoretical concepts of professional PD management and may enable the development of novel, personalized care approaches.
Collapse
Affiliation(s)
- Marlena van Munster
- Department of Neurology, University Hospital Marburg, 35033 Marburg, Germany; (F.T.); (D.J.P.)
| | - Johanne Stümpel
- Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health (CERES), University of Cologne, 50931 Cologne, Germany;
- Research Unit Ethics, University Hospital Cologne, 50931 Cologne, Germany
| | - Franziska Thieken
- Department of Neurology, University Hospital Marburg, 35033 Marburg, Germany; (F.T.); (D.J.P.)
| | - David J. Pedrosa
- Department of Neurology, University Hospital Marburg, 35033 Marburg, Germany; (F.T.); (D.J.P.)
| | - Angelo Antonini
- Parkinson and Movement Disorders Unit, University of Padua, 35122 Padua, Italy;
| | - Diane Côté
- The Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada;
| | - Margherita Fabbri
- Department of Neurosciences, Clinical Investigation Center CIC 1436, Parkinson Toulouse Expert Center, NS-Park/FCRIN Network and NeuroToul COEN Center, TOULOUSE University Hospital, INSERM, University of Toulouse 3, 31062 Toulouse, France;
| | - Joaquim J. Ferreira
- Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal;
- Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
- CNS—Campus Neurológico Sénior Torres Vedras, 2560-280 Torres Vedras, Portugal
| | - Evžen Růžička
- Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University, General University Hospital in Prague, CZ-121 08 Prague, Czech Republic;
| | - David Grimes
- Parkinson Disease and Movement Disorders Centre, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Research Institute, Ottawa, ON K1Y 4E9, Canada; (D.G.); (T.A.M.)
| | - Tiago A. Mestre
- Parkinson Disease and Movement Disorders Centre, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Research Institute, Ottawa, ON K1Y 4E9, Canada; (D.G.); (T.A.M.)
| |
Collapse
|
9
|
Martello J, Shulman LM, Barr E, Gruber-Baldini A, Armstrong MJ. Assessment of Parkinson disease quality measures on 12-month patient outcomes. Neurol Clin Pract 2019; 10:58-64. [PMID: 32190421 DOI: 10.1212/cpj.0000000000000745] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2019] [Accepted: 08/15/2019] [Indexed: 11/15/2022]
Abstract
Background Quality measures (QMs) exist to operationalize guidelines by measuring adherence to guidelines through documentation, ultimately leading to improved patient outcomes. Studies are rare looking at the relationship between adherence to Parkinson disease (PD) QMs and patient outcomes. Methods We assessed adherence of our movement disorders specialists (MDSs) to the American Academy of Neurology's 2010 PD QM set through chart review using the measure set work group's criteria of documentation. We then evaluated patient outcomes to see whether there was a correlation with adherence to these QMs. Results Ninety-seven consecutive patients met the inclusion criteria. The mean disease duration was 9.3 (5.8) years. All patients were assessed by 1 of 4 MDSs. A total of 68% of QMs were documented across all patients. There was a small positive correlation between the number of documented QMs the year before the index visit and the number of calls/emails both the year before and after the index visit (r = 0.20, p = 0.04 and r = 0.26, p = 0.01, respectively.) There was a small negative correlation between the number of documented QMs and the number of PD follow-up visits the year after the index visit (r = -0.19, p = 0.05.) No other outcome showed a statistically significant correlation with the adherence to documented QMs. Conclusions We found no clinically important improvement in patient outcomes with higher adherence levels. It is important that QM developers validate QMs to ensure that they fulfill the intended goal of improved patient outcomes.
Collapse
Affiliation(s)
- Justin Martello
- Department of Neurosciences (JM), Christiana Care Health System, Newark, DE; Department of Neurology (LMS), University of Maryland School of Medicine, Baltimore, MD; Department of Epidemiology and Public Health (EB, AGB), University of Maryland School of Medicine, Baltimore, MD; and Department of Neurology (MJA), University of Florida College of Medicine, Gainesville, FL
| | - Lisa M Shulman
- Department of Neurosciences (JM), Christiana Care Health System, Newark, DE; Department of Neurology (LMS), University of Maryland School of Medicine, Baltimore, MD; Department of Epidemiology and Public Health (EB, AGB), University of Maryland School of Medicine, Baltimore, MD; and Department of Neurology (MJA), University of Florida College of Medicine, Gainesville, FL
| | - Erik Barr
- Department of Neurosciences (JM), Christiana Care Health System, Newark, DE; Department of Neurology (LMS), University of Maryland School of Medicine, Baltimore, MD; Department of Epidemiology and Public Health (EB, AGB), University of Maryland School of Medicine, Baltimore, MD; and Department of Neurology (MJA), University of Florida College of Medicine, Gainesville, FL
| | - Ann Gruber-Baldini
- Department of Neurosciences (JM), Christiana Care Health System, Newark, DE; Department of Neurology (LMS), University of Maryland School of Medicine, Baltimore, MD; Department of Epidemiology and Public Health (EB, AGB), University of Maryland School of Medicine, Baltimore, MD; and Department of Neurology (MJA), University of Florida College of Medicine, Gainesville, FL
| | - Melissa J Armstrong
- Department of Neurosciences (JM), Christiana Care Health System, Newark, DE; Department of Neurology (LMS), University of Maryland School of Medicine, Baltimore, MD; Department of Epidemiology and Public Health (EB, AGB), University of Maryland School of Medicine, Baltimore, MD; and Department of Neurology (MJA), University of Florida College of Medicine, Gainesville, FL
| |
Collapse
|